Raul Y Krauss

age ~61

from Chestnut Hill, MA

Get Report

Also known as:

Raul Krauss
Raul Crauss
Raul Kauss

Connected to:

Raul Krauss Phones & Addresses

Chestnut Hill, MA
Newton Center, MA
20 Holden St, Cambridge, MA 02138 • 6176617393

Work

Company:

Vertex pharmaceuticals
Jan 2007 to 2016
Position:

Head: multiple sclerosis disease area team

Education

School / High School:

Harvard Business School Online
2016 to 2016

Skills

Drug Discovery • Biotechnology • Neuroscience • Pharmaceutical Industry • Neurology • Neurobiology • Life Sciences • Cell Biology • Research • Molecular Biology • Consulting • R&D • Cell • Immunohistochemistry • In Vivo • Cell Culture • Drug Development • Pharmacology • Lifesciences • Clinical Development • Assay Development • Clinical Research • Immunology • Mammalian Cell Culture • Glia • Research and Development

Languages

English • Spanish • French

Industries

Biotechnology

Us Patents

Bmp-9 Compositions And Methods For Inducing Differentiation Of Cholinergic Neurons
view source
US Patent:

20050222028, Oct 6, 2005
Filed:

Dec 14, 2004
Appl. No.:

11/011791
Inventors:

Jan Blusztajn - Cambridge MA, US
Raul Krauss - Cambridge MA, US
R. Thies - Andover MA, US
International Classification:

A61K038/17
US Classification:

514012000
Abstract:

BMP-9 compositions and methods for their use are disclosed. The BMP-9 compositions act as a differentiating factor for the cholinergic phenotype of CNS neurons. The compositions may be used in the treatment of diseases and disorders caused by degeneration and/or malfunctioning of cholinergic neurons.

Cell Adhesion-Mediating Proteins And Polynucleotides Encoding Them
view source
US Patent:

20040249145, Dec 9, 2004
Filed:

Nov 7, 2003
Appl. No.:

10/704363
Inventors:

Karen Stark - Arlington MA, US
Alix Weaver - Northbridge MA, US
Heidi Hoffmann - Lunenberg MA, US
Raul Krauss - Newton MA, US
Kulvinder Saini - Haryana, IN
Dario Valenzuela - Houston TX, US
International Classification:

C07K014/705
C07H021/04
US Classification:

536/023500, 435/069100, 435/320100, 435/325000, 530/350000
Abstract:

The present invention provides multiple polynucleotide sequences from the same novel gene, the exons comprising the polynucleotide sequences, and the proteins encoded by the polynucleotide sequences. Three splicing variant polynucleotides were isolated from prostate tissue. The polypeptides, including the splicing variants, have a region of hydrophobicity indicative of a transmembrane domain and all three extracellular and cytoplasmic domains.

Resumes

Vice President And Co-Founder | Head Of Biology

view source

Location:

Los Angeles, CA

Industry:

Biotechnology

Work:

Vertex Pharmaceuticals Jan 2007 - 2016
Head: Multiple Sclerosis Disease Area Team
Vertex Pharmaceuticals Mar 1, 2014 - 2016
Co-Head North America, Neurology Disease Area Team
Disarm Therapeutics Mar 1, 2014 - 2016
Vice President and Co-Founder | Head of Biology
Vertex Pharmaceuticals 2007 - 2012
Research Scientist and Senior Research Scientist
Biogen 2005 - 2005
Research Scientist, Neurobiology and Molecular Discovery

Education:

Harvard Business School Online 2016 - 2016
Harvard University 1997
Doctorates, Doctor of Philosophy, Neuroscience Harvard Business School Online 1975 - 1980
Harvard University;Phd, Neuroscience;1997;
Doctorates, Doctor of Philosophy, Neuroscience Harvard Medical School

Skills:

Drug Discovery
Biotechnology
Neuroscience
Pharmaceutical Industry
Neurology
Neurobiology
Life Sciences
Cell Biology
Research
Molecular Biology
Consulting
R&D
Cell
Immunohistochemistry
In Vivo
Cell Culture
Drug Development
Pharmacology
Lifesciences
Clinical Development
Assay Development
Clinical Research
Immunology
Mammalian Cell Culture
Glia
Research and Development

Languages:

English
Spanish
French